3'-氨基-3-联苯醇 | 779341-19-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3'-氨基-3-联苯醇
• 英文名称: 3-(3-hydroxyphenyl)aniline
• 英文别名: 3-(3-Aminophenyl)phenol
• CAS: 779341-19-4
• 化学式: C₁₂H₁₁NO
• mdl: MFCD04117380
• 分子量: 185.225
• InChiKey: BFTXLAFWQOHRMU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2922299090

反应信息

• 作为反应物：
  描述：

  3'-氨基-3-联苯醇 在 碳酸氢钠 、 三乙胺 作用下， 以 甲苯 为溶剂， 反应 52.0h， 生成 cyclohexylcarbamic acid 3'-benzyloxycarbonylaminobiphenyl-3-yl ester
  参考文献：
  名称：

  Cyclohexylcarbamic Acid 3‘- or 4‘-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors:  Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling Studies

  摘要：

  Fatty acid amide hydrolase (FAAH) is a promising target for modulating endocannabinoid and fatty acid ethanolamide signaling, which may have important therapeutic potential. We recently described a new class of O-arylcarbamate inhibitors of FAAH, including the cyclohexylcarbamic acid biphenyl-3-yl ester URB524 (half-maximal inhibitory concentration, IC50 = 63 nM), which have significant anxiolytic-like properties in rats. In the present study, by introducing a selected group of substituents at the meta and para positions of the distal phenyl ring of URB524, we have characterized structure-activity profiles for this series of compounds and shown that introduction of small polar groups in the meta position greatly improves inhibitory potency. Most potent in the series was the m-carbamoyl derivative URB597 (4i, IC50 = 4.6 nM). Furthermore, quantitative structure-activity relationship (QSAR) analysis of an extended set of meta-substituted derivatives revealed a negative correlation between potency and lipophilicity and suggested that small-sized substituents may undertake polar interactions with the binding pocket of the enzyme. Docking studies and molecular dynamics simulations, using the crystal structure of FAAH, indicated that the O-biphenyl scaffold of the carbamate inhibitors can be accommodated within a lipophilic region of the substrate-binding site, where their folded shape mimics the initial 10-12 carbon atoms of the arachidonyl moiety of anandamide (a natural FAAH substrate) and methyl arachidonyl fluorophosphonate (a nonselective FAAH inhibitor). Moreover, substituents at the meta position of the distal. phenyl ring can form hydrogen bonds with atoms located on the polar section of a narrow channel pointing toward the membrane-associated side of the enzyme. The structure-activity characterization reported here should help optimize the pharmacodynamic and pharmacokinetic properties of this class of compounds.

  DOI：

  10.1021/jm031140x
• 作为产物：
  描述：

  3-(3-甲氧基苯基)苯胺 在 氢碘酸 作用下， 以 水 为溶剂， 反应 5.0h， 以54%的产率得到3'-氨基-3-联苯醇
  参考文献：
  名称：

  [EN] HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS
  [FR] MODULATEURS ALLOSTÉRIQUES DES PROTÉINES DU NOYAU DE L'HÉPATITE B

  摘要：

  摘要 本公开提供了部分具有对乙型肝炎病毒Cp具有变构效应的化合物。本文还提供了治疗病毒感染（如乙型肝炎）的方法，包括向需要的患者施用所述化合物。

  公开号：

  WO2015138895A1

文献信息

• Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution
  作者：Thuy Nguyen、Nadezhda German、Ann M. Decker、Tiffany L. Langston、Thomas F. Gamage、Charlotte E. Farquhar、Jun-Xu Li、Jenny L. Wiley、Brian F. Thomas、Yanan Zhang

  DOI：10.1021/acs.jmedchem.7b00707

  日期：2017.9.14

  Allosteric modulators of the cannabinoid CB1 receptor have recently been reported as an alternative approach to modulate the CB1 receptor for therapeutic benefits. In this study, we report the design and synthesis of a series of diarylureas derived from PSNCBAM-1 (2). Similar to 2, these diarylureas dose-dependently inhibited CP55,940-induced intracellular calcium mobilization and [35S]GTP-γ-S binding

  最近有报道称，大麻素CB1受体的变构调节剂是调节CB1受体的另一种治疗方法。在这项研究中，我们报告了一系列源自PSNCBAM-1（2）的二芳基脲的设计和合成。与2相似，这些二芳基脲剂量依赖性地抑制CP55,940诱导的细胞内钙动员和[ 35 S]GTP-γ-S结合，同时增强[ 3 H] CP55,940与CB1受体的结合。结构-活性关系研究表明2的吡啶基环可以被其他芳族环取代，而CB1变构调节不需要吡咯烷基环。34（RTICBM-74）在所有体外测定中的功效均与2相似，但对大鼠肝微粒体的代谢稳定性显着提高。更重要的是，在减轻大鼠熄灭的可卡因寻求行为的恢复方面，34比2更有效，证明了该二芳基脲系列有潜力成为可卡因成瘾复发治疗发展的有希望的候选者。
• [EN] DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS<br/>[FR] DIARYLURÉES EN TANT QUE MODULATEURS ALLOSTÉRIQUES DE CB1
  申请人：RTI INT

  公开号：WO2018209030A1

  公开（公告）日：2018-11-15

  The present invention provides novel diarylurea derivatives (compounds of formula (I)) and their uses. The compounds of the present invention are demonstrated to be allosteric modulators of the CB1 receptor, and therefore useful for the treatment of diseases and conditions mediated by CB1.

  本发明提供了新颖的二芳基脲衍生物（式（I）化合物）及其用途。本发明的化合物被证明是CB1受体的变构调节剂，因此对于治疗由CB1介导的疾病和症状是有用的。
• Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
  申请人：Gaviraghi Giovanni

  公开号：US20080275028A1

  公开（公告）日：2008-11-06

  The present invention relates to compounds with α7 nAChR agonistic activity, processes for their preparation, pharmaceutical compositions containing the same and the use thereof for the treatment of neurological, psychiatric, cognitive, immunological and inflammatory disorders.

  本发明涉及具有α7 nAChR激动活性的化合物，其制备方法，含有该化合物的制药组合物以及用于治疗神经、精神、认知、免疫和炎症性疾病的用途。
• PHTHALAZINE DERIVATIVES
  申请人：Araldi Gian-Luca

  公开号：US20080146547A1

  公开（公告）日：2008-06-19

  The present invention relates to novel phthalazine derivatives and, more particularly, to phthalazine derivatives that are useful as protein kinase inhibitors. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  本发明涉及新的邻苯二酸嗪衍生物，更具体地，涉及可用作蛋白激酶抑制剂的邻苯二酸嗪衍生物。本发明还涉及制备这些化合物的方法，含有这些化合物的组合物，以及使用这些化合物的治疗方法。
• METHOD FOR PRODUCING BIARYL COMPOUND
  申请人：Sato Koichi

  公开号：US20100087680A1

  公开（公告）日：2010-04-08

  A method for producing a biaryl compound, comprising reacting an aromatic organic compound with at least one compound selected from the group consisting of aromatic organoboron compounds and boroxine compounds, in the presence of a zero-valent nickel catalyst, phosphine ligand and base.

  一种制备双芳基化合物的方法，包括在零价镍催化剂、膦配体和碱的存在下，将芳香有机化合物与选自芳香基有机硼化合物和硼氧化物化合物组的至少一种化合物反应。